therapy for acquired immunodeficiency syndrome. implantation of cultured thymic fragments [editorial]

NLM AIDSLINE Therapy for acquired immunodeficiency syndrome. Implantation of cultured thymic fragments [editorial] Phair J
September 30, 1986

Arch Intern Med. 1986 Jun;146(6):1074-5. Unique Identifier : AIDSLINE Acquired Immunodeficiency Syndrome/IMMUNOLOGY/THERAPY Human Immunotherapy/METHODS Thymus Gland/TRANSPLANTATION EDITORIAL JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common EDITORIAL: Focusing the Spotlight on Lack of Access to Health Information CALIFORNIA: No Link Found Between Vaccines, Guillain-Barre Syndrome CALIFORNIA: No Link Found Between Vaccines, Guillain-Barre Syndrome Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies UCLA study suggests potential therapy for HIV Anti-HIV therapy appears to protect children's hearts, NIH network study shows CALIFORNIA: Formal HCV Education Improved Time to Therapy Initiation, Response New Therapy for the Management of HIV-associated Enteropathy from Entera Health KS-associated IRIS common among people starting HIV therapy in Africa
Information in this article was accurate in September 30, 1986. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.